35Pharma is a clinical-stage biopharmaceutical company specializing in TGF-beta superfamily therapeutics for the treatment of Cardiometabolic Disease and Obesity. 35Pharma leverages its scientific leadership in TGF-beta biology combined with superior protein engineering to discover innovative compounds that selectively and potently neutralize validated pathological TGF-beta ligands while sparing beneficial homeostatic ligands.
We believe in connecting rigorous science with our innate sense of urgency to rapidly generate breakthrough therapies for patients in need of a better quality of life.
Our beautiful R&D and office facilities are located in the heart of Montreal, Canada, where a diverse team of industry professionals work together to execute on our mission to serve patients in need.
If our corporate culture and dedication to patients resonate with you, we invite you to join our team: https://35pharma.com/careers/
Company Details
- Employees
- 50
- Address
- Facilities Are Located In The Heart Of Montreal
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.35pharma.com
- Keywords
- Laval.
35pharma Questions
35Pharma's website is http://www.35pharma.com
35Pharma's LinkedIn profile is https://www.linkedin.com/company/35-pharma
35Pharma has
50 employees.
View email and phone details for 50
employees at 35Pharma.
35Pharma's industry is
Biotechnology Research
35Pharma's top competitors are
Cellcarta,
Altasciences,
Pharmascience,
Ixm Labs,
Nomic Bio,
Forbius,
Hypermabs Inc.,
Novartis,
Repare Therapeutics,
Indero (Formerly Innovaderm).
35Pharma's categories are Biotechnology Research
